Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Application of FSME-IMMUN in obese persons
2014-000570-19Phase 4Completed
- Sponsor
- Institute of Specific Prophylaxis and Tropical Medicine
- Start
- Jun 2014
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Institute of Specific Prophylaxis and Tropical Medicine. Primary endpoint: Humoral immunity based on TBE neutralization test titers. Started Jun 2014; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2014-000570-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000570-19.